The United Laboratories ULIHF Stock
The United Laboratories Price Chart
The United Laboratories ULIHF Financial and Trading Overview
| The United Laboratories stock price | 1.43 USD |
| Previous Close | 0.88 USD |
| Open | 0.88 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.88 - 0.88 USD |
| 52 Week Range | 0.41 - 0.88 USD |
| Volume | 100 USD |
| Avg. Volume | 1 USD |
| Market Cap | 1.67B USD |
| Beta (5Y Monthly) | 0.388505 |
| PE Ratio (TTM) | 7.3375 |
| EPS (TTM) | 0.2 USD |
| Forward Dividend & Yield | 0.03 (3.13%) |
| Ex-Dividend Date | July 5, 2023 |
| 1y Target Est | N/A |
ULIHF Valuation Measures
| Enterprise Value | -679047168 USD |
| Trailing P/E | 7.3375 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.14775652 |
| Price/Book (mrq) | 0.1508222 |
| Enterprise Value/Revenue | -0.06 |
| Enterprise Value/EBITDA | -0.267 |
Trading Information
The United Laboratories Stock Price History
| Beta (5Y Monthly) | 0.388505 |
| 52-Week Change | 61.55% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.88 USD |
| 52 Week Low | 0.41 USD |
| 50-Day Moving Average | 0.79 USD |
| 200-Day Moving Average | 0.6 USD |
ULIHF Share Statistics
| Avg. Volume (3 month) | 1 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 1.82B |
| Float | 902.14M |
| Short Ratio | N/A |
| % Held by Insiders | 50.35% |
| % Held by Institutions | 8.93% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.19 |
| Trailing Annual Dividend Yield | 21.57% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.1511 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 13.94% |
| Operating Margin (ttm) | 17.77% |
| Gross Margin | 43.84% |
| EBITDA Margin | 22.39% |
Management Effectiveness
| Return on Assets (ttm) | 7.13% |
| Return on Equity (ttm) | 15.84% |
Income Statement
| Revenue (ttm) | 11.33B USD |
| Revenue Per Share (ttm) | 6.23 USD |
| Quarterly Revenue Growth (yoy) | 23.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | 2.54B USD |
| Net Income Avi to Common (ttm) | 1.58B USD |
| Diluted EPS (ttm) | 0.12 |
| Quarterly Earnings Growth (yoy) | 160.69% |
Balance Sheet
| Total Cash (mrq) | 4.74B USD |
| Total Cash Per Share (mrq) | 2.61 USD |
| Total Debt (mrq) | 2.46B USD |
| Total Debt/Equity (mrq) | 23.21 USD |
| Current Ratio (mrq) | 1.779 |
| Book Value Per Share (mrq) | 5.838 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.03B USD |
| Levered Free Cash Flow (ttm) | 619.01M USD |
Profile of The United Laboratories
| Country | United States |
| State | N/A |
| City | Yuen Long |
| Address | 6 Fuk Wang Street |
| ZIP | N/A |
| Phone | 852 2687 1033 |
| Website | https://www.tul.com.cn |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 14000 |
The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules, as well as active pharmaceutical ingredients and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, rest of Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
Q&A For The United Laboratories Stock
What is a current ULIHF stock price?
The United Laboratories ULIHF stock price today per share is 1.43 USD.
How to purchase The United Laboratories stock?
You can buy ULIHF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for The United Laboratories?
The stock symbol or ticker of The United Laboratories is ULIHF.
Which industry does the The United Laboratories company belong to?
The The United Laboratories industry is Drug Manufacturers-Specialty & Generic.
How many shares does The United Laboratories have in circulation?
The max supply of The United Laboratories shares is 2.3B.
What is The United Laboratories Price to Earnings Ratio (PE Ratio)?
The United Laboratories PE Ratio is 7.12499950 now.
What was The United Laboratories earnings per share over the trailing 12 months (TTM)?
The United Laboratories EPS is 0.2 USD over the trailing 12 months.
Which sector does the The United Laboratories company belong to?
The The United Laboratories sector is Healthcare.